Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

NARI

Inari Medical Inc

May 17 • 04:00PM ET

45.75

Dollar change -0.55
Percentage change -1.19	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IJR IWM VTI VB VXF VBK IWO IHI IJT IJS

Index	RUT	P/E	-	EPS (ttm)	-0.41	Insider Own	15.02%	Shs Outstand	57.76M	Perf Week	4.57%
Market Cap	2.66B	Forward P/E	234.08	EPS next Y	0.20	Insider Trans	-1.90%	Shs Float	49.41M	Perf Month	18.40%
Income	-23.62M	PEG	-	EPS next Q	-0.20	Inst Own	91.01%	Short Float	8.93%	Perf Quarter	-21.71%
Sales	520.66M	P/S	5.11	EPS this Y	-1398.33%	Inst Trans	0.07%	Short Ratio	3.09	Perf Half Y	-25.05%
Book/sh	7.71	P/B	5.93	EPS next Y	143.48%	ROA	-4.04%	Short Interest	4.41M	Perf Year	-33.64%
Cash/sh	1.75	P/C	26.13	EPS next 5Y	-	ROE	-5.41%	52W Range	36.73 - 71.85	Perf YTD	-29.53%
Dividend Est.	-	P/FCF	128.75	EPS past 5Y	32.83%	ROI	-4.95%	52W High	-36.33%	Beta	1.00
Dividend TTM	-	Quick Ratio	2.19	Sales past 5Y	197.48%	Gross Margin	86.33%	52W Low	24.56%	ATR (14)	1.82
Dividend Ex-Date	-	Current Ratio	2.71	EPS Y/Y TTM	23.19%	Oper. Margin	-1.75%	RSI (14)	62.06	Volatility	3.91% 4.05%
Employees	1300	Debt/Eq	0.07	Sales Y/Y TTM	26.10%	Profit Margin	-4.54%	Recom	1.45	Target Price	65.82
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	-931.36%	Payout	-	Rel Volume	0.60	Prev Close	46.30
Sales Surprise	3.89%	EPS Surprise	-40.82%	Sales Q/Q	23.27%	Earnings	Apr 30 AMC	Avg Volume	1.43M	Price	45.75
SMA20	10.74%	SMA50	8.27%	SMA200	-18.51%	Trades		Volume	857,115	Change	-1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-29-24	Downgrade	Piper Sandler	Overweight → Neutral	$85 → $55
Jan-23-24	Initiated	Needham	Buy	$72
Jul-19-23	Initiated	Robert W. Baird	Outperform	$79
Oct-12-22	Initiated	Jefferies	Buy	$88
Sep-29-22	Initiated	Berenberg	Buy	$85
Sep-13-22	Initiated	Truist	Hold	$87
Jun-21-22	Initiated	Piper Sandler	Overweight	$100
Mar-23-22	Resumed	BofA Securities	Buy	$105
Dec-15-20	Upgrade	Wells Fargo	Equal Weight → Overweight	$79
Nov-18-20	Initiated	BTIG Research	Buy	$92
Oct-29-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$66 → $76
Sep-28-20	Initiated	SVB Leerink	Outperform	$80
Jun-19-20	Initiated	Canaccord Genuity	Buy
Jun-16-20	Initiated	Wells Fargo	Equal Weight	$49
Jun-16-20	Initiated	Morgan Stanley	Equal-Weight	$52
Jun-16-20	Initiated	BofA/Merrill	Neutral	$56

Show Previous Ratings

May-18-24 02:36AM	Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI) (GuruFocus.com)
May-17-24 11:10AM	Inari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices Hagens Berman (GlobeNewswire)
May-15-24 07:41AM	Inari Medical (NARI) Fell on Investor Concerns (Insider Monkey)
May-14-24 08:15PM	Inari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices Hagens Berman (GlobeNewswire)
May-07-24 12:20PM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
07:00AM	Loading…
May-06-24 07:00AM	Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference (GlobeNewswire)
May-04-24 02:30AM	Director William Hoffman Sells Shares of Inari Medical Inc (NARI) (GuruFocus.com)
May-03-24 05:49PM	Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing (MT Newswires)
12:02PM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
May-02-24 04:07PM	Inari Medical, Inc. (NASDAQ:NARI) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 12:19PM	Inari Medical Shares Jump on Higher Q1 Revenue (MT Newswires) +11.41%
10:59AM	Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises (Zacks)
07:42AM	Q1 2024 Inari Medical Inc Earnings Call (Thomson Reuters StreetEvents)
03:30AM	Inari Medical Inc (NARI) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
Apr-30-24 09:55PM	NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:45PM	Loading…
05:45PM	Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:41PM	Inari Medical Inc (NARI) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Rising Operating ... (GuruFocus.com)
04:05PM	Inari Medical Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 03:31PM	Investor News Announces Civil Investigative Demand Served to Inari Medical by U.S. Department of Justice Contact Johnson Fistel, LLP (GlobeNewswire)
Apr-22-24 10:26AM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-19-24 10:09AM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-18-24 01:25PM	Inari Medical, Inc. (NARI) Downgraded by Analysts Due to Pending DOJ Probe Hagens Berman (GlobeNewswire)
Apr-17-24 04:05PM	Inari Medical to Announce First Quarter 2024 Financial Results (GlobeNewswire)
Apr-15-24 10:52AM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-11-24 04:05PM	Inari Medical Announces the Release of 2023 Ethos and Sustainability Report (GlobeNewswire)
03:33PM	Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. ( Inari or the Company ) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm (GlobeNewswire)
Apr-09-24 11:04AM	Why You Should Retain Inari Medical (NARI) Stock for Now (Zacks)
Apr-02-24 04:05PM	Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives (GlobeNewswire)
Mar-29-24 11:30AM	Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-25-24 06:15PM	AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600 (PR Newswire)
07:01PM	Loading…
Mar-20-24 07:01PM	Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI) (GuruFocus.com)
Mar-14-24 10:45AM	Inari Medical's (NARI) ClotTriever Improves Patient Outcome (Zacks)
Mar-12-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm (GlobeNewswire)
04:05PM	Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry (GlobeNewswire)
Mar-08-24 11:30PM	Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm (GlobeNewswire)
Mar-07-24 10:44AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Feb-29-24 03:37PM	Inari Medical Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire) -20.84%
11:32AM	Inari Medical (NARI) Q4 Earnings Improve Y/Y, Gross Margin Down (Zacks)
11:16AM	Inari Medical, Inc. (NASDAQ:NARI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:43AM	Q4 2023 Inari Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:37PM	Inari Medical Inc (NARI) Reports Growth Amidst Operating Losses in Q4 2023 (GuruFocus.com)
04:05PM	Inari Medical Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-23-24 07:16AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Jan-15-24 03:13AM	Is Inari Medical (NARI) a Worthy Investment? (Insider Monkey)
Jan-12-24 12:16PM	Inari (NARI) Preliminary Q4 Revenues Ride on Procedure Demand (Zacks)
Jan-09-24 06:30AM	Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance (GlobeNewswire) -10.08%
Jan-08-24 09:00AM	OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER (PR Newswire)
Dec-20-23 04:01PM	Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-23 07:24AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Dec-01-23 11:31AM	Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-30-23 11:19AM	Inari Medical's (NARI) PEERLESS II RCT to Boost Patient Outcome (Zacks)
Nov-27-23 04:20PM	Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT) (GlobeNewswire)
Nov-18-23 07:03AM	Insider Sell Alert: Director William Hoffman Sells 25,000 Shares of Inari Medical Inc (NARI) (GuruFocus.com)
Nov-15-23 04:05PM	Inari Medical Closes Acquisition of LimFlow (GlobeNewswire)
07:59AM	Reasons to Retain Inari Medical (NARI) in Your Portfolio Now (Zacks)
Nov-06-23 09:35AM	Inari Medical, Inc. (NARI) Loses -27.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +8.80%
Nov-03-23 12:27PM	Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates (Zacks) -5.28%
10:59AM	Teleflex (TFX) Q3 Earnings Top Estimates, 2023 Outlook Up (Zacks)
10:31AM	Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up (Zacks)
08:59AM	Penumbra (PEN) Q3 Earnings Top Estimates, Margins Increase (Zacks)
07:01AM	Inari Medical to buy limb-saving device maker LimFlow for up to $415M (MedTech Dive)
Nov-02-23 07:16PM	Inari Medical, Inc. (NASDAQ:NARI) Q3 2023 Earnings Call Transcript (Insider Monkey) -16.97%
04:01PM	Inari Medical to Present at Upcoming Investor Conferences (GlobeNewswire)
11:03AM	Exact Sciences (EXAS) Q3 Earnings Beat, Gross Margin Rises (Zacks)
11:02AM	Q3 2023 Inari Medical Inc Earnings Call (Thomson Reuters StreetEvents)
10:24AM	Envista (NVST) Q3 Earnings Miss Estimates, Gross Margin Down (Zacks)
Nov-01-23 06:54PM	Inari Medical Inc (NARI) Reports Q3 2023 Earnings: Revenue Up 31.4%, Net Income of $3.2 Million (GuruFocus.com)
05:01PM	LimFlow Announces Agreement to Be Acquired by Inari Medical (Business Wire)
04:02PM	Inari Medical Reports Third Quarter 2023 Financial Results (GlobeNewswire)
04:01PM	Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow (GlobeNewswire)
11:07AM	CVS Health (CVS) Q3 Earnings Surpass Estimates, Margins Up (Zacks)
09:53AM	IDEXX (IDXX) Q3 Earnings Top Estimates, '23 Sales View Down (Zacks)
Oct-31-23 07:37AM	QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down (Zacks)
07:33AM	Medical Device Stocks to Watch for Earnings on Nov 1: MCK & More (Zacks)
Oct-30-23 09:48AM	Zacks Industry Outlook Highlights Alcon, STERIS and Inari Medical (Zacks)
Oct-27-23 10:12AM	3 Medical Instruments Stocks Countering Industry-Wide Headwinds (Zacks)
08:08AM	Chemed (CHE) Q3 Earnings and Revenues Surpass, Margins Rise (Zacks)
08:01AM	ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down (Zacks)
Oct-26-23 10:36AM	Labcorp (LH) Q3 Earnings and Revenues Beat, Margins Fall (Zacks)
07:14AM	Align Technology (ALGN) Q3 Earnings Miss, Operating Margin Up (Zacks)
Oct-18-23 10:23PM	Director William Hoffman Sells 25,000 Shares of Inari Medical Inc (GuruFocus.com)
06:12AM	3 Solid Stocks to Buy for Superb Earnings Acceleration (Zacks)
Oct-11-23 04:01PM	Inari Medical to Announce Third Quarter 2023 Financial Results (GlobeNewswire) -12.29%
12:08PM	Unraveling the Future of Inari Medical Inc (NARI): A Deep Dive into Key Metrics (GuruFocus.com)
Oct-06-23 08:43AM	Reasons to Add Inari Medical (NARI) Stock to Your Portfolio (Zacks)
Sep-14-23 07:03PM	CFO Mitch Hill Sells 6,500 Shares of Inari Medical Inc (GuruFocus.com)
Aug-24-23 04:01PM	Inari Medical to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 09:55AM	Wall Street Analysts See a 36.39% Upside in Inari Medical, Inc. (NARI): Can the Stock Really Move This High? (Zacks) +5.92%
Aug-08-23 01:26PM	Shockwave Medical (SWAV) Q2 Earnings Miss, Revenues Surge Y/Y (Zacks) -5.24%
Aug-06-23 08:56AM	Is Inari Medical, Inc. (NASDAQ:NARI) Expensive For A Reason? A Look At Its Intrinsic Value (Simply Wall St.)
Aug-05-23 05:21AM	2 Top Healthcare Stocks I'd Buy Now Without Hesitation (Motley Fool)
Aug-04-23 08:59AM	Inari Medical (NARI) Q2 Earnings Top, Revenues Rise Y/Y (Zacks)
Aug-03-23 02:26PM	Why Shares of Inari Medical Are Up Thursday (Motley Fool) +21.64%
Aug-02-23 05:25PM	Inari Medical, Inc. (NARI) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:01PM	Inari Medical Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:01PM	Inari Medical to Present at the 43rd Annual Canaccord Growth Conference (GlobeNewswire)
Jul-20-23 07:09AM	Should You Think About Buying Inari Medical, Inc. (NASDAQ:NARI) Now? (Simply Wall St.)
Jul-13-23 04:01PM	Inari Medical to Announce Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-04-23 07:19AM	Reasons to Add Inari Medical (NARI) Stock to Your Portfolio (Zacks)

Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoffman William	Director	May 16 '24	Sale	46.60	40,000	1,863,977	925,359	May 17 06:07 PM
Hill, Mitch C.	Chief Financial Officer	May 13 '24	Option Exercise	0.46	6,000	2,742	187,294	May 15 04:39 PM
Hill, Mitch C.	Chief Financial Officer	May 13 '24	Sale	45.97	6,000	275,812	181,294	May 15 04:39 PM
Hoffman William	Director	May 01 '24	Sale	42.00	38,549	1,619,047	965,359	May 03 05:40 PM
Hoffman William	Director	Apr 16 '24	Sale	40.00	1,451	58,040	999,782	Apr 18 06:38 PM
Hill, Mitch C.	Chief Financial Officer	Apr 12 '24	Option Exercise	0.46	6,000	2,742	187,294	Apr 16 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Apr 12 '24	Sale	40.96	6,000	245,760	181,294	Apr 16 04:32 PM
Hoffman William	Director	Mar 18 '24	Sale	41.13	40,000	1,645,079	1,003,296	Mar 20 04:34 PM
Hill, Mitch C.	Chief Financial Officer	Mar 12 '24	Option Exercise	0.46	6,000	2,742	189,361	Mar 14 04:31 PM
Hill, Mitch C.	Chief Financial Officer	Mar 12 '24	Sale	41.91	6,000	251,461	183,361	Mar 14 04:31 PM
Hoffman William	Director	Dec 15 '23	Sale	65.08	25,000	1,627,073	1,045,493	Dec 19 05:18 PM
Hill, Mitch C.	Chief Financial Officer	Dec 12 '23	Option Exercise	0.46	6,500	2,970	176,730	Dec 14 04:35 PM
Hill, Mitch C.	Chief Financial Officer	Dec 12 '23	Sale	62.75	6,500	407,855	170,230	Dec 14 04:35 PM
Hoffman William	Director	Dec 04 '23	Option Exercise	0.43	103,492	44,336	1,070,493	Dec 06 05:07 PM
Hykes Andrew	President and CEO	Nov 16 '23	Sale	59.82	37,448	2,240,277	434,817	Nov 17 07:17 PM
Tu Thomas	Chief Medical Officer	Nov 16 '23	Sale	59.82	25,451	1,522,573	320,932	Nov 17 07:19 PM
Hoffman William	Director	Nov 15 '23	Sale	61.24	25,000	1,531,124	967,001	Nov 17 06:27 PM
Hill, Mitch C.	Chief Financial Officer	Nov 13 '23	Option Exercise	0.46	6,500	2,970	176,730	Nov 15 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Nov 13 '23	Sale	56.06	6,500	364,366	170,230	Nov 15 04:32 PM
MILDER DONALD B	Director	Nov 08 '23	Buy	53.48	2,100	112,303	3,031,714	Nov 08 05:48 PM
MILDER DONALD B	Director	Nov 07 '23	Buy	53.44	54,000	2,885,760	3,029,614	Nov 08 05:48 PM
Hoffman William	Director	Oct 16 '23	Sale	57.28	25,000	1,432,098	992,001	Oct 18 05:39 PM
Hill, Mitch C.	Chief Financial Officer	Oct 12 '23	Option Exercise	0.46	6,500	2,970	176,730	Oct 16 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Oct 12 '23	Sale	55.74	6,500	362,340	170,230	Oct 16 04:32 PM
Hoffman William	Director	Sep 15 '23	Sale	66.74	25,000	1,668,503	1,023,055	Sep 19 04:38 PM
Hill, Mitch C.	Chief Financial Officer	Sep 12 '23	Option Exercise	0.46	6,500	2,970	178,302	Sep 14 04:41 PM
Hill, Mitch C.	Chief Financial Officer	Sep 12 '23	Sale	67.85	6,500	441,040	171,802	Sep 14 04:41 PM
Hykes Andrew	President and CEO	Aug 16 '23	Sale	66.11	36,676	2,424,829	475,132	Aug 18 05:05 PM
Tu Thomas	Chief Medical Officer	Aug 16 '23	Sale	66.11	24,926	1,647,980	347,997	Aug 18 05:01 PM
Hoffman William	Director	Aug 15 '23	Sale	69.02	25,000	1,725,537	1,048,055	Aug 17 04:46 PM
Hill, Mitch C.	Chief Financial Officer	Aug 14 '23	Option Exercise	0.46	6,500	2,970	178,302	Aug 16 04:46 PM
Hill, Mitch C.	Chief Financial Officer	Aug 14 '23	Sale	70.47	6,500	458,053	171,802	Aug 16 04:46 PM
Hoffman William	Director	Jul 17 '23	Sale	57.08	25,000	1,426,914	1,073,055	Jul 19 04:32 PM
Hill, Mitch C.	Chief Financial Officer	Jul 12 '23	Option Exercise	0.46	6,500	2,970	177,982	Jul 14 04:35 PM
Hill, Mitch C.	Chief Financial Officer	Jul 12 '23	Sale	56.24	6,500	365,540	171,482	Jul 14 04:35 PM
Hoffman William	Director	Jun 15 '23	Sale	57.74	25,000	1,443,576	1,098,055	Jun 16 04:42 PM
Hill, Mitch C.	Chief Financial Officer	Jun 12 '23	Option Exercise	0.46	6,500	2,970	179,554	Jun 13 05:48 PM
Hill, Mitch C.	Chief Financial Officer	Jun 12 '23	Sale	59.24	6,500	385,088	173,054	Jun 13 05:48 PM
ROOT JONATHAN D	Director	May 27 '23	Option Exercise	0.00	2,982	0	537,023	May 30 04:37 PM
Nielsen Kirk G.	Director	May 27 '23	Option Exercise	0.00	2,982	0	61,479	May 30 04:35 PM
MILDER DONALD B	Director	May 27 '23	Option Exercise	0.00	2,982	0	255,000	May 30 04:38 PM

Open in Screener

EW

Edwards Lifesciences Corp

May 17 • 04:00PM ET

89.14

Dollar change -0.97
Percentage change -1.08	%

Healthcare • Medical Devices • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

EW Edwards Lifesciences Corp daily Stock Chart

Held by: VTI VOO IVV VUG IHI IWF VHT QUAL RSP SCHG

Index	S&P 500	P/E	38.31	EPS (ttm)	2.33	Insider Own	1.61%	Shs Outstand	601.10M	Perf Week	2.79%
Market Cap	53.72B	Forward P/E	28.63	EPS next Y	3.11	Insider Trans	-4.18%	Shs Float	592.93M	Perf Month	3.11%
Income	1.41B	PEG	4.06	EPS next Q	0.69	Inst Own	83.76%	Short Float	1.62%	Perf Quarter	3.53%
Sales	6.14B	P/S	8.74	EPS this Y	10.43%	Inst Trans	-0.08%	Short Ratio	2.88	Perf Half Y	33.02%
Book/sh	11.82	P/B	7.54	EPS next Y	12.34%	ROA	15.38%	Short Interest	9.63M	Perf Year	1.69%
Cash/sh	2.82	P/C	31.58	EPS next 5Y	9.44%	ROE	21.59%	52W Range	60.57 - 96.12	Perf YTD	16.90%
Dividend Est.	-	P/FCF	197.92	EPS past 5Y	15.35%	ROI	18.14%	52W High	-7.26%	Beta	1.12
Dividend TTM	-	Quick Ratio	2.67	Sales past 5Y	10.28%	Gross Margin	76.11%	52W Low	47.17%	ATR (14)	2.03
Dividend Ex-Date	-	Current Ratio	3.75	EPS Y/Y TTM	-3.43%	Oper. Margin	27.71%	RSI (14)	54.73	Volatility	2.38% 2.22%
Employees	19800	Debt/Eq	0.10	Sales Y/Y TTM	11.68%	Profit Margin	23.01%	Recom	2.03	Target Price	96.55
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	4.50%	Payout	0.00%	Rel Volume	0.62	Prev Close	90.11
Sales Surprise	1.80%	EPS Surprise	2.66%	Sales Q/Q	9.50%	Earnings	Apr 25 AMC	Avg Volume	3.34M	Price	89.14
SMA20	3.02%	SMA50	-0.95%	SMA200	13.67%	Trades		Volume	2,063,356	Change	-1.08%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-24	Upgrade	Deutsche Bank	Hold → Buy
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102
Mar-29-23	Initiated	UBS	Neutral	$84
Mar-08-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $78
Feb-06-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-31-23	Downgrade	Bernstein	Outperform → Underperform	$95 → $66
Jan-30-23	Downgrade	Piper Sandler	Overweight → Neutral	$95 → $80
Dec-06-22	Downgrade	Stifel	Buy → Hold	$95 → $75
Oct-28-22	Downgrade	Oppenheimer	Outperform → Perform
Oct-26-22	Initiated	Mizuho	Buy	$100
Oct-18-22	Initiated	Barclays	Overweight	$96
Oct-12-22	Initiated	Jefferies	Buy	$110
Jul-29-22	Downgrade	Canaccord Genuity	Buy → Hold	$115 → $106

Show Previous Ratings

May-14-24 04:33PM	Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint (Benzinga)
07:53AM	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 (MT Newswires)
May-13-24 05:52PM	Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing (MT Newswires)
02:20PM	Market Chatter: Edwards Lifesciences Faces EU Antitrust Complaint By Meril (MT Newswires)
May-08-24 07:21PM	Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability (Business Wire)
07:52AM	Loading…
May-07-24 07:52AM	Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 (MT Newswires)
May-01-24 05:27PM	Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing (MT Newswires)
09:40AM	Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year? (Zacks)
09:35AM	Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW) (Zacks)
Apr-30-24 05:03PM	Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing (MT Newswires)
10:20AM	Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 02:22PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:18PM	Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends (Zacks)
07:23AM	Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 (MT Newswires)
Apr-26-24 04:09PM	This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss (Investor's Business Daily)
11:21AM	Loading…
11:21AM	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 (MT Newswires)
11:09AM	Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up (Zacks)
10:54AM	Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 (MT Newswires)
10:42AM	UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating (MT Newswires)
10:38AM	Q1 2024 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
10:29AM	Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85 (MT Newswires)
09:53AM	Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86 (MT Newswires)
08:28AM	Edwards gets Q1 boost as Pascal valve repair sales ramp up (MedTech Dive)
03:40AM	Edwards Lifesciences Corp (EW) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
Apr-25-24 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics (Zacks)
05:52PM	Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates (GuruFocus.com)
05:30PM	Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates (Zacks)
05:04PM	Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff (Investor's Business Daily)
04:34PM	Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set (MT Newswires)
04:26PM	Edwards Lifesciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Loading…
04:15PM	Edwards Lifesciences Reports First Quarter Results (Business Wire)
Apr-23-24 06:14AM	Boston Scientific, Dexcom and Edwards next as earnings season rolls on (MedTech Dive)
Apr-22-24 09:16AM	Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-19-24 01:08AM	Spinoffs, sales and tuck-ins top medtech deal priorities: Moodys (MedTech Dive)
Apr-18-24 10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:10AM	Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 (Business Wire)
Apr-17-24 11:01AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings? (Zacks)
Apr-12-24 04:37AM	Abbotts Nadim Geloo on Triclips US launch, Edwards competition (MedTech Dive)
Apr-07-24 04:30PM	Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It (Business Wire)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 09:40AM	Are Medical Stocks Lagging Edwards Lifesciences (EW) This Year? (Zacks)
Mar-19-24 02:24PM	Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark (Investor's Business Daily)
01:38PM	Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It? (Zacks)
Mar-15-24 04:02PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:50AM	Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It? (Zacks)
Mar-13-24 11:57AM	Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable (Zacks)
Mar-11-24 02:00PM	Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR (Business Wire)
Mar-07-24 04:57PM	S&P 500 Gains and Losses Today: Index Notches Record Close Ahead of Jobs Report (Investopedia) +6.20%
11:31AM	Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-06-24 09:43AM	Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth (Zacks)
Feb-26-24 11:54AM	Here's Why You Should Buy Edward Lifesciences (EW) Stock Now (Zacks)
Feb-23-24 07:05AM	Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference (Business Wire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-15-24 09:36AM	Edwards (EW) Gains From Balanced Core Growth and New Launches (Zacks)
Feb-13-24 12:09AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Feb-09-24 02:21AM	Edwards Lifesciences Corp Director Heisz Stone Sells 7,056 Shares (GuruFocus.com)
Feb-07-24 04:11PM	Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says But Its Stock Isn't (Investor's Business Daily)
11:19AM	Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:31AM	Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip (Zacks)
09:06AM	Q4 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
05:54AM	How Edwards Evoque valve won an early nod from the FDA (MedTech Dive)
Feb-06-24 07:55PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Edwards Lifesciences (EW) Q4 Earnings Match Estimates (Zacks)
04:54PM	Edwards Lifesciences Corp (EW) Reports Robust Q4 and Full-Year 2023 Financial Results (GuruFocus.com)
04:44PM	Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat (Investor's Business Daily)
04:40PM	Edwards Lifesciences: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
07:18AM	Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System (Zacks)
Feb-02-24 07:00AM	Edwards EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve (Business Wire) +9.38%
06:27AM	Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment (MedTech Dive)
Feb-01-24 09:15AM	Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:44AM	Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength? (Zacks)
Jan-30-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024 (Business Wire)
06:15AM	4 heart device trends shaping the medtech sector in 2024 (MedTech Dive)
Jan-23-24 07:07AM	Edwards risks TAVR market share slip amid challenges from Abbott, Boston Scientific: survey (MedTech Dive)
Jan-19-24 11:26AM	What's in Store for Edwards Lifesciences (EW) in Q4 Earnings? (Zacks)
Jan-16-24 01:20AM	Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth (Insider Monkey)
Jan-03-24 07:40AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Jan-02-24 09:00AM	Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-23 05:24AM	Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3 (Insider Monkey)
Dec-14-23 07:49PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
Dec-11-23 12:27PM	Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook (Zacks)
Dec-08-23 05:11AM	Edwards to spin off its critical care business (MedTech Dive)
Dec-07-23 05:00PM	S&P 500 Gains and Losses Today: AI Excitement Powers AMD, Alphabet (Investopedia)
08:30AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Nov-26-23 05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 06:58AM	Could Ozempic Harm These 3 Medical Device Stocks? (Motley Fool)
Nov-24-23 11:31AM	Edwards Lifesciences (EW) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-23-23 06:06AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Oct-30-23 11:40AM	ITGR or EW: Which Is the Better Value Stock Right Now? (Zacks)
Oct-27-23 07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 06:15PM	Why Edwards Lifesciences Stock Plummeted Today (Motley Fool) -8.14%
03:06PM	CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION (PR Newswire)
02:00PM	TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION (PR Newswire)
11:33AM	Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:17AM	Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip (Zacks)
11:12AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:08AM	CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View (Zacks)
07:23AM	Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Option Exercise	45.28	5,000	226,384	52,750	May 13 05:45 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Sale	87.81	5,000	439,038	47,750	May 13 05:45 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Option Exercise	36.75	857	31,495	25,333	May 09 07:40 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Sale	85.60	857	73,359	23,890	May 09 07:40 PM
Zovighian Bernard J	CEO	May 06 '24	Buy	85.74	580	49,753	3,268	May 07 05:53 PM
Chopra Daveen	CVP, TMTT	May 04 '24	Option Exercise	0.00	4,713	0	27,172	May 06 07:17 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 04 '24	Option Exercise	0.00	5,855	0	45,144	May 06 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 04 '24	Option Exercise	0.00	7,465	0	25,905	May 06 07:18 PM
Szyman Catherine M.	CVP, Critical Care	May 04 '24	Option Exercise	0.00	5,796	0	49,018	May 06 07:18 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 04 '24	Option Exercise	0.00	4,157	0	177,969	May 06 07:18 PM
Wood Larry L	Global President TAVR & Surg	May 04 '24	Option Exercise	0.00	6,675	0	220,022	May 06 07:17 PM
Zovighian Bernard J	CEO	May 04 '24	Option Exercise	0.00	6,265	0	50,554	May 07 05:53 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Option Exercise	36.75	29,350	1,078,612	33,836	May 02 06:05 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Sale	84.77	29,350	2,487,966	4,486	May 02 06:05 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Option Exercise	36.75	14,400	529,200	188,249	May 01 05:17 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Sale	84.21	14,400	1,212,687	173,849	May 01 05:17 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Option Exercise	36.75	7,250	266,438	26,324	Apr 30 04:56 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Sale	85.80	7,250	622,062	19,074	Apr 30 04:56 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Option Exercise	45.28	8,658	392,006	222,452	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Option Exercise	36.75	8,000	294,000	47,503	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Sale	74.62	29,350	2,190,043	4,486	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Sale	71.86	8,658	622,164	213,794	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Sale	71.86	8,000	574,880	39,503	Dec 13 07:04 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Option Exercise	59.26	3,500	207,398	27,450	Dec 06 05:01 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Sale	70.00	3,500	245,006	23,950	Dec 06 05:01 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Option Exercise	36.75	6,000	220,500	45,503	Nov 13 05:21 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Sale	65.30	8,660	565,460	213,794	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Sale	65.30	6,000	391,780	39,503	Nov 13 05:21 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Nov 06 06:33 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Sale	67.18	29,350	1,971,733	4,486	Nov 06 06:33 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Oct 31 05:22 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Sale	62.66	7,255	454,569	19,248	Oct 31 05:22 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Option Exercise	36.75	5,000	183,750	44,503	Oct 13 05:01 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Sale	70.00	8,660	606,198	213,794	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Sale	69.98	5,000	349,909	39,503	Oct 13 05:01 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Option Exercise	36.75	5,000	183,750	39,814	Oct 10 06:23 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Sale	72.68	5,000	363,400	34,814	Oct 10 06:23 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Option Exercise	59.26	8,500	503,682	32,450	Oct 03 04:58 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Sale	70.00	8,500	595,000	23,950	Oct 03 04:58 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Oct 02 06:51 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Sale	68.84	29,350	2,020,454	4,486	Oct 02 06:51 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Option Exercise	36.75	7,255	266,621	26,503	Sep 29 04:49 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Sale	69.54	7,255	504,527	19,248	Sep 29 04:49 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Option Exercise	45.28	8,660	392,096	222,454	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Sep 14 08:00 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Sale	73.63	8,660	637,615	213,794	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Sale	73.71	4,500	331,695	39,503	Sep 14 08:00 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Option Exercise	36.75	5,000	183,750	39,814	Sep 08 05:29 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Sale	76.00	5,000	380,000	34,814	Sep 08 05:29 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Option Exercise	59.26	8,500	503,682	32,450	Sep 06 05:09 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Sale	76.07	8,500	646,609	23,950	Sep 06 05:09 PM

Open in Screener

OM

Outset Medical Inc

May 17 • 04:00PM ET

3.61

Dollar change +0.09
Percentage change 2.56	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IWM VTI VXF IWO SCHA VTWO VHT PRFZ DFAS VTWG

Index	RUT	P/E	-	EPS (ttm)	-3.38	Insider Own	8.19%	Shs Outstand	50.32M	Perf Week	17.59%
Market Cap	186.71M	Forward P/E	-	EPS next Y	-1.24	Insider Trans	-2.44%	Shs Float	47.49M	Perf Month	60.44%
Income	-168.77M	PEG	-	EPS next Q	-0.45	Inst Own	95.99%	Short Float	19.90%	Perf Quarter	5.87%
Sales	125.08M	P/S	1.49	EPS this Y	37.64%	Inst Trans	-4.91%	Short Ratio	7.04	Perf Half Y	-30.04%
Book/sh	1.80	P/B	2.00	EPS next Y	26.21%	ROA	-47.61%	Short Interest	9.45M	Perf Year	-82.05%
Cash/sh	4.39	P/C	0.82	EPS next 5Y	-	ROE	-109.06%	52W Range	1.92 - 24.13	Perf YTD	-33.27%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-15.08%	ROI	-57.39%	52W High	-85.04%	Beta	1.97
Dividend TTM	-	Quick Ratio	5.32	Sales past 5Y	202.67%	Gross Margin	24.61%	52W Low	88.02%	ATR (14)	0.38
Dividend Ex-Date	-	Current Ratio	6.42	EPS Y/Y TTM	4.07%	Oper. Margin	-130.48%	RSI (14)	61.85	Volatility	9.77% 11.90%
Employees	480	Debt/Eq	2.17	Sales Y/Y TTM	5.74%	Profit Margin	-134.93%	Recom	2.25	Target Price	5.64
Option/Short	Yes / Yes	LT Debt/Eq	2.16	EPS Q/Q	12.95%	Payout	-	Rel Volume	0.56	Prev Close	3.52
Sales Surprise	-7.19%	EPS Surprise	-3.64%	Sales Q/Q	-15.83%	Earnings	May 08 AMC	Avg Volume	1.34M	Price	3.61
SMA20	19.68%	SMA50	41.47%	SMA200	-40.68%	Trades		Volume	749,331	Change	2.56%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-08-24	Initiated	BTIG Research	Buy	$6
Apr-05-24	Upgrade	CL King	Neutral → Buy	$6
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$14 → $6
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform	$32 → $3
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform	$23
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48 → $20
Mar-02-22	Resumed	BofA Securities	Buy	$50
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$50
Aug-18-21	Initiated	Cowen	Outperform	$70
Apr-19-21	Initiated	Wells Fargo	Overweight	$63
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	SVB Leerink	Mkt Perform	$60
Oct-12-20	Initiated	Stifel	Buy	$54
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight	$48
Oct-12-20	Initiated	Goldman	Buy	$54
Oct-12-20	Initiated	BofA Securities	Buy	$54
Oct-12-20	Initiated	Barclays	Overweight

Show Previous Ratings

May-13-24 06:59AM	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating (MT Newswires)
May-10-24 03:48PM	Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses (GuruFocus.com) -6.12%
May-09-24 03:44PM	Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript (Insider Monkey) -20.82%
09:42AM	Q1 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
03:57AM	Outset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
08:58PM	Loading…
May-08-24 08:58PM	OM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +8.97%
05:45PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports First Quarter 2024 Financial Results (Business Wire)
May-06-24 08:48AM	Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell (MT Newswires) +20.70%
08:00AM	Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance (Business Wire)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 04:30PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire) +12.65%
Apr-19-24 08:30AM	Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)
Apr-18-24 01:36PM	Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis (Zacks)
Apr-17-24 08:30AM	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S. (Business Wire)
08:30AM	Loading…
Apr-15-24 08:30AM	Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care (Business Wire)
Mar-13-24 04:02PM	Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors (Business Wire)
Mar-05-24 03:34PM	Why Dialysis Stocks Are up Today (The Wall Street Journal)
Feb-26-24 09:00AM	Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference (Business Wire)
Feb-22-24 10:51AM	Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.23%
07:10AM	Q4 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:49PM	Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-20-24 04:25PM	ROLLINS, INC. ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS (PR Newswire)
Feb-05-24 10:00AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) +5.76%
08:30AM	Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024 (Business Wire)
Jan-08-24 08:30AM	Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance (Business Wire)
Jan-03-24 08:30AM	Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-29-23 04:05PM	Outset Medical to Present at BofA Home Care Conference (Business Wire) +5.70%
Nov-25-23 11:43AM	5 Struggling Stocks to Buy at a Discount (Motley Fool)
06:30AM	Loading…
Nov-23-23 06:30AM	2 of the Cheapest Stocks I Own (Motley Fool)
Nov-16-23 02:46PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm's Attorneys (GlobeNewswire)
Nov-09-23 04:05PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Nov-07-23 04:31PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
04:05PM	Outset Medical Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for (Zacks) +7.18%
09:35AM	After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM) (Zacks)
Nov-01-23 09:00AM	New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo Hemodialysis System on Equitable Kidney Care (Business Wire) +6.21%
Oct-31-23 02:00PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm (GlobeNewswire) +15.31%
10:01AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-23 04:05PM	Outset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 (Business Wire)
Oct-27-23 11:42AM	Hagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-19-23 12:31PM	Outset Medical (PM) Investigated for Possible Securities Law Violations, Hagens Berman Encourages Investors with Losses to Contact its Attorneys (GlobeNewswire) -6.67%
Oct-17-23 05:36PM	Outset Medical, Inc.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
09:35AM	Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM) (Zacks)
Oct-16-23 08:14AM	Outset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call Transcript (Insider Monkey) +15.04%
Oct-13-23 07:21PM	Outset Medical stock nosedives due to FDA warning letter headwinds Hagens Berman (GlobeNewswire) -49.93%
09:50AM	Netflix downgraded, Applied Materials upgraded: Wall Street's top analyst calls (The Fly)
Oct-12-23 04:05PM	Outset Medical Reports Preliminary Third Quarter 2023 Financial Results (Business Wire) -11.33%
Aug-29-23 04:05PM	Outset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-14-23 09:24PM	Investors Look at Apple, Amazon, and More (Motley Fool)
Aug-02-23 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-13-23 08:30AM	Outset Medical to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023 (Business Wire)
Jul-10-23 01:09PM	Why Shares of Outset Medical Are Down Monday (Motley Fool) -5.87%
10:48AM	Shareholders in These 2 Stocks Got Nasty Surprises Monday (Motley Fool)
Jun-15-23 06:56AM	Getting In Cheap On Outset Medical, Inc. (NASDAQ:OM) Might Be Difficult (Simply Wall St.)
Jun-06-23 04:05PM	Outset Medical to Present at Goldman Sachs 44th Annual Global Healthcare Conference (Business Wire) +6.06%
May-30-23 07:30AM	The Ultimate Growth Stocks to Buy With $1,400 Right Now (Motley Fool)
May-05-23 06:14AM	Outset Medical First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-04-23 09:13AM	Q1 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 06:35PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +5.02%
04:05PM	Outset Medical Reports First Quarter 2023 Financial Results (Business Wire)
Apr-30-23 05:50AM	Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. (Motley Fool)
Apr-25-23 08:30AM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Apr-23-23 07:03AM	This Could Be the Best Growth Stock Under $20 on the Market Right Now (Motley Fool)
Apr-12-23 09:05AM	Outset Medical to Present Research Highlighting Home Hemodialysis Success for Underserved Populations at National Kidney Foundation Spring Clinical Meetings (Business Wire)
08:30AM	Outset Medical to Report First Quarter 2023 Financial Results on Wednesday, May 3, 2023 (Business Wire)
Apr-03-23 07:01AM	Outset Medical (NASDAQ:OM) investors are sitting on a loss of 61% if they invested a year ago (Simply Wall St.)
Mar-25-23 08:26AM	There's More to the Mint Mobile Deal Than Ryan Reynolds (Motley Fool)
Feb-22-23 04:05PM	Outset Medical to Present at 43rd Annual Cowen Health Care Conference (Business Wire)
Feb-17-23 04:16PM	Outset Medical, Inc. (NASDAQ:OM) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-15-23 05:54AM	Better Medtech Stock to Buy: InMode or Outset Medical? (Motley Fool) -6.06%
Feb-14-23 12:10PM	Why Shares of Outset Medical Are Down Tuesday (Motley Fool) -5.94%
Feb-13-23 05:45PM	Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-07-23 10:00AM	Computer Programs and Systems (CPSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-06-23 10:00AM	Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jan-25-23 08:30AM	Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023 (Business Wire)
Jan-09-23 08:30AM	Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance (Business Wire)
Jan-03-23 06:10PM	Why Outset Medical's Shares Rose 22.5% in December (Motley Fool)
Dec-23-22 05:20AM	Supercharged Returns: 2 Growth Stocks That Could Turn $1,000 Into $10,000 (Motley Fool)
Dec-22-22 11:21AM	Do You Think Outset Medical (OM) Has Low Growth Rates? (Insider Monkey)
Dec-20-22 04:05PM	Outset Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-22 08:00AM	Outset Medical to Present at the BofA Securities Home Care Conference (Business Wire) -6.37%
Nov-26-22 05:00AM	2 No-Brainer Stocks to Buy Now That Could Soar in 2023 (Motley Fool)
Nov-16-22 09:09AM	Outset Medical Ranked Number 33 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500 (Business Wire)
Nov-11-22 01:15PM	RBC Capital Initiates Coverage On This MedTech Stock Citing 'Differentiated Offering' (Benzinga)
Nov-09-22 07:24PM	2 Big Stock Winners From a Horrible Day on Wall Street (Motley Fool) +29.90%
04:05PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Nov-08-22 06:25PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.50%
04:05PM	Outset Medical Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-04-22 08:30AM	Outset Medical Secures Up To $300 Million in Debt Financing (Business Wire)
Oct-27-22 09:00AM	Outset Medical Presenting Research on Human Factors Testing, Home Dialysis Patient Experience and More During ASN Kidney Week 2022 (Business Wire)
Oct-26-22 04:05PM	Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022 (Business Wire)
Oct-24-22 06:36AM	Outset Medical (NASDAQ:OM) shareholders have endured a 72% loss from investing in the stock a year ago (Simply Wall St.)
Sep-21-22 03:24AM	Change Healthcare (CHNG) Soars 6.4%: Is Further Upside Left in the Stock? (Zacks)
Aug-30-22 04:05PM	Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference (Business Wire)
Aug-15-22 09:00AM	Outset Medical Awarded VA Contract Aimed at Improving Dialysis Care for Veterans (Business Wire)
Aug-09-22 09:44AM	Why Outset Medical Is Worth a Look (Motley Fool)

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trigg Leslie	Chair and CEO	May 16 '24	Sale	3.53	5,237	18,487	915,804	May 17 05:25 PM
Ahmed Nabeel	Chief Financial Officer	May 16 '24	Sale	3.53	3,918	13,831	318,959	May 17 05:40 PM
Brottem John L.	General Counsel	May 16 '24	Sale	3.53	2,972	10,491	243,875	May 17 05:36 PM
Nash Marc	SVP Operations and R&D	May 16 '24	Sale	3.53	1,097	3,872	241,413	May 17 05:38 PM
Racine Jean-Olivier	Chief Technology Officer	May 10 '24	Sale	3.27	8,306	27,161	265,325	May 10 06:19 PM
Nash Marc	SVP Operations and R&D	Mar 15 '24	Sale	2.13	2,391	5,093	242,510	Mar 15 06:40 PM
Ahmed Nabeel	Chief Financial Officer	Mar 01 '24	Sale	3.15	1,584	4,990	322,877	Mar 04 04:34 PM
Trigg Leslie	Chair and CEO	Feb 15 '24	Sale	3.57	5,320	18,992	833,091	Feb 16 05:29 PM
Ahmed Nabeel	Chief Financial Officer	Feb 15 '24	Sale	3.57	4,403	15,719	312,594	Feb 16 05:24 PM
Brottem John L.	General Counsel	Feb 15 '24	Sale	3.57	3,341	11,927	245,046	Feb 16 05:26 PM
Williamson Steven S.	Chief Commercial Officer	Feb 15 '24	Sale	3.57	2,500	8,925	320,347	Feb 16 05:31 PM
Racine Jean-Olivier	Chief Technology Officer	Feb 15 '24	Sale	3.57	1,866	6,662	271,830	Feb 16 05:28 PM
Nash Marc	SVP Operations and R&D	Feb 15 '24	Sale	3.57	617	2,203	243,100	Feb 16 05:27 PM
Nash Marc	SVP Operations and R&D	Jan 16 '24	Sale	429.00	678	290,862	243,717	Jan 17 08:01 PM
Trigg Leslie	Chair and CEO	Jan 16 '24	Sale	4.29	8,126	34,861	838,411	Jan 17 08:03 PM
Ahmed Nabeel	Chief Financial Officer	Jan 16 '24	Sale	4.29	1,726	7,405	316,997	Jan 17 07:59 PM
Brottem John L.	General Counsel	Jan 16 '24	Sale	4.29	1,480	6,349	248,387	Jan 17 08:00 PM
Williamson Steven S.	Chief Commercial Officer	Jan 16 '24	Sale	4.29	996	4,273	322,847	Jan 17 08:04 PM
Porter Stacey L.	Chief People Officer	Jan 16 '24	Sale	4.29	768	3,295	61,448	Jan 17 08:02 PM
Racine Jean-Olivier	Chief Technology Officer	Jan 16 '24	Sale	4.29	723	3,102	273,696	Jan 17 08:03 PM
Trigg Leslie	Chair and CEO	Jan 08 '24	Sale	5.49	14,188	77,892	389,099	Jan 08 08:34 PM
Ahmed Nabeel	Chief Financial Officer	Jan 08 '24	Sale	5.49	10,709	58,792	76,819	Jan 08 08:29 PM
Brottem John L.	General Counsel	Jan 08 '24	Sale	5.49	7,344	40,319	48,807	Jan 08 08:30 PM
Williamson Steven S.	Chief Commercial Officer	Jan 08 '24	Sale	5.49	7,055	38,732	105,939	Jan 08 08:35 PM
Porter Stacey L.	Chief People Officer	Jan 08 '24	Sale	5.49	4,766	26,165	58,630	Jan 08 08:31 PM
Racine Jean-Olivier	Chief Technology Officer	Jan 08 '24	Sale	5.49	3,905	21,438	73,781	Jan 08 08:33 PM
Williamson Steven S.	Chief Commercial Officer	Nov 16 '23	Sale	4.76	3,584	17,060	112,994	Nov 17 04:22 PM
Trigg Leslie	Chair and CEO	Nov 16 '23	Sale	4.76	3,175	15,113	403,287	Nov 17 04:19 PM
Ahmed Nabeel	Chief Financial Officer	Nov 16 '23	Sale	4.76	1,643	7,821	87,528	Nov 17 04:08 PM
Brottem John L.	General Counsel	Nov 16 '23	Sale	4.76	1,431	6,812	56,151	Nov 17 04:15 PM
Racine Jean-Olivier	Chief Technology Officer	Nov 16 '23	Sale	4.76	790	3,760	77,686	Nov 17 04:18 PM
Porter Stacey L.	Chief People Officer	Nov 16 '23	Sale	4.76	671	3,194	63,396	Nov 17 04:17 PM
Nash Marc	SVP Operations and R&D	Nov 16 '23	Sale	4.76	562	2,675	44,757	Nov 17 04:15 PM
Ahmed Nabeel	Chief Financial Officer	Sep 01 '23	Sale	13.61	545	7,417	89,171	Sep 05 04:04 PM
Trigg Leslie	Chair and CEO	Aug 16 '23	Sale	15.10	3,028	45,723	406,461	Aug 17 04:41 PM
Ahmed Nabeel	Chief Financial Officer	Aug 16 '23	Sale	15.10	1,565	23,632	89,171	Aug 17 04:26 PM
Brottem John L.	General Counsel	Aug 16 '23	Sale	15.10	1,364	20,596	57,581	Aug 17 04:28 PM
Racine Jean-Olivier	Chief Technology Officer	Aug 16 '23	Sale	15.10	752	11,355	78,475	Aug 17 04:39 PM
Porter Stacey L.	Chief People Officer	Aug 16 '23	Sale	15.10	638	9,634	64,066	Aug 17 04:37 PM
Williamson Steven S.	Chief Commercial Officer	Aug 16 '23	Sale	15.10	635	9,588	116,577	Aug 17 04:43 PM
Nash Marc	SVP Operations and R&D	Aug 16 '23	Sale	15.10	535	8,078	44,998	Aug 17 04:34 PM
Trigg Leslie	Chair and CEO	Aug 01 '23	Option Exercise	4.11	20,000	82,200	429,489	Aug 03 04:11 PM
Trigg Leslie	Chair and CEO	Aug 01 '23	Sale	20.22	20,000	404,462	409,489	Aug 03 04:11 PM
Ahmed Nabeel	Chief Financial Officer	Aug 01 '23	Sale	20.07	990	19,869	90,736	Aug 03 04:10 PM
Brottem John L.	General Counsel	Jul 19 '23	Option Exercise	9.48	1,415	13,414	60,360	Jul 20 04:01 PM
Brottem John L.	General Counsel	Jul 19 '23	Sale	20.00	1,415	28,300	58,945	Jul 20 04:01 PM
Trigg Leslie	Chair and CEO	Jul 03 '23	Option Exercise	4.11	20,000	82,200	429,489	Jul 05 05:39 PM
Trigg Leslie	Chair and CEO	Jul 03 '23	Sale	20.90	20,000	417,944	409,489	Jul 05 05:39 PM
Ahmed Nabeel	Chief Financial Officer	Jul 03 '23	Sale	21.70	990	21,483	91,726	Jul 05 05:38 PM
Brottem John L.	General Counsel	Jun 20 '23	Option Exercise	9.48	1,414	13,405	60,359	Jun 21 04:01 PM
Brottem John L.	General Counsel	Jun 20 '23	Sale	21.97	1,414	31,066	58,945	Jun 21 04:01 PM
Trigg Leslie	Chair and CEO	Jun 01 '23	Option Exercise	4.11	20,000	82,200	429,489	Jun 01 06:08 PM
Trigg Leslie	Chair and CEO	Jun 01 '23	Sale	21.10	20,000	421,920	409,489	Jun 01 06:08 PM
Ahmed Nabeel	Chief Financial Officer	Jun 01 '23	Sale	20.83	990	20,622	92,716	Jun 01 05:31 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

NARI

Inari Medical Inc

EW

Edwards Lifesciences Corp

OM

Outset Medical Inc

Upgrade your FINVIZ experience